logo
Don't underestimate the power of the 'brocast', Mark Cuban says

Don't underestimate the power of the 'brocast', Mark Cuban says

Mark Cuban said on Monday that politicians should start paying more attention to podcast bros if they want to connect with young people.
"Brocasts aren't republican. They are for young guys. If you want to connect you have to speak to them. If you want to lose by 248k votes in 7 swing states, ignore them," Cuban wrote in a post on Bluesky.
Cuban is no stranger to the world of politics and podcasts.
The "Shark Tank" star endorsed Vice President Kamala Harris in last year's presidential election. Cuban also hit the podcast circuit to campaign for Harris, appearing on shows like Theo Von's "This Past Weekend" and the "All-In" podcast.
While Cuban made the comment in relation to elections, the power of the "brocast" is on clear display when it comes to businesses as well.
Besides chatting about politics, Cuban has also gone on podcasts to talk about his business ventures.
Last week, Cuban went on the "Hims House" podcast, where he discussed the origins of his low-cost online pharmacy, Cost Plus Drugs.
"Going back to 2018 or 2017, being here in Texas, I had some Republican friends who were asking me questions like, 'Do you have any ideas how the Republicans can replace the ACA, Obamacare?'" Cuban said.
"I'm like: 'No, but it's an interesting question. Let me see if I can come up with some ideas.' So that got me into healthcare. The ideas, you know, never got that far, but it really got me, turned me into a healthcare geek," he added.
To be sure, Cuban isn't the only one who has recognized the value of podcasts in connecting with a wider audience. Business leaders like Elon Musk, Mark Zuckerberg, and Sundar Pichai have been making their rounds on the podcast circuit to talk about their companies or share their views on work and life.
Last month, Zuckerberg appeared on Theo Von's podcast, where he shared his take on the value of attending college.
"I'm not sure that college is preparing people for, like, the jobs that they need to have today," Zuckerberg said on the podcast. "I think there's a big issue on that, and like all the student debt issues are like really big issues."
And in April, too, Melinda French Gates recorded a podcast episode with Scott Galloway, where she talked about the criticism she's faced for her philanthropic efforts.
"I'm not sitting on the sidelines. To me, it's so easy to sit on the sidelines and, as Roosevelt used to say, criticize from the sidelines. I'm in the arena doing the work," French Gates said.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Elon Musk Slams Trump's Spending Bill: ‘A Disgusting Abomination'
Elon Musk Slams Trump's Spending Bill: ‘A Disgusting Abomination'

Yahoo

time26 minutes ago

  • Yahoo

Elon Musk Slams Trump's Spending Bill: ‘A Disgusting Abomination'

A serious rift has erupted between Elon Musk and President Trump over the massive government spending bill the president has urged Congress to pass. Musk, who donated nearly $275 million toward Trump's 2024 election campaign, on Tuesday posted on X an unambiguous denunciation of the bill, which is called the One Big, Beautiful Bill Act. More from Variety London Mayor Sadiq Khan Hails 'Adolescence' for Having 'Mainstreamed' Conversation About 'Epidemic' of Violence Against Women Jon Stewart Tackles Elon Musk's Exit From the Trump Administration: 'This Guy Has Seen Some S--' Elon Musk Says New York Times Is 'Lying Their Ass Off' About His Alleged Drug Use; Newspaper Defends Coverage 'I'm sorry, but I just can't stand it anymore. This massive, outrageous, pork-filled Congressional spending bill is a disgusting abomination,' Musk wrote. 'Shame on those who voted for it: you know you did wrong. You know it.' The tech mogul wrote that the bill 'will massively increase the already gigantic budget deficit' and that 'Congress is making America bankrupt.' Musk, the world's richest person, also posted a warning that voters would 'fire all politicians who betrayed the American people' in the 2026 midterm elections. On May 28, Musk announced the he would end his tenure as a 'special government employee' — leading the White House's Department of Government Efficiency, or DOGE — after 128 days. Per the U.S. Department of the Interior, a person cannot serve in such a role for more than 130 days in a consecutive year. Sen. Ran Paul (R-Kentucky) was among those chiming in to agree with Musk. 'We have both seen the massive waste in government spending and we know another $5 trillion in debt is a huge mistake. We can and must do better,' he wrote, quoting Musk's post. Trump, on Truth Social, earlier in the day slammed Paul, writing 'Rand Paul has very little understanding of the BBB, especially the tremendous GROWTH that is coming. He loves voting 'NO' on everything, he thinks it's good politics, but it's not. The BBB is a big WINNER!!!' At a White House press briefing, Fox News correspondent Peter Doocy asked press secretary Karoline Leavitt 'how mad do you think President Trump is going to be' about Musk's comments? Leavitt responded that Trump 'already knows where Elon Musk stood on this bill. It doesn't change the president's opinion. This is one big, beautiful bill, and he's sticking to it.' The One Big, Beautiful Bill Act passed the Republican-controlled House but has yet to clear the Senate. The legislation would make Trump's 2017 tax cuts permanent (with wealthy Americans benefiting the most) and increase funding for the U.S. military and immigration enforcement. In addition, the version that passed the House cuts funding for health, nutrition, education and clean energy programs. Musk has criticized the 'Big Beautiful Bill' before, but using tamer terminology. Last week, for example, Musk criticized Trump's 'massive spending bill' in an interview with CBS's 'Sunday Morning,' saying the legislation 'undermines the work' of DOGE. Best of Variety What's Coming to Netflix in June 2025 New Movies Out Now in Theaters: What to See This Week 'Harry Potter' TV Show Cast Guide: Who's Who in Hogwarts?

Trump says this ‘grandstander' Republican should be voted out of office
Trump says this ‘grandstander' Republican should be voted out of office

Yahoo

time27 minutes ago

  • Yahoo

Trump says this ‘grandstander' Republican should be voted out of office

President Donald Trump wants to see voters oust Rep. Thomas Massie, R-KY. The 47th president made this wish clear to reporters on Tuesday during a trip to Capitol Hill to coalesce House Republican support for his tax and immigration bill known as the 'big beautiful bill.' During the visit, one reporter asked Trump whether he agreed with Massie, who on X suggested that the bill's passage would result in bigger deficits and 'Biden levels of spending.' 'No, I don't think Thomas Massie understands government. I think he's a grandstander frankly. We don't even talk to him much,' Trump said. 'I think he should be voted out of office. And I just don't think he understands government. If you ask him a couple of questions, he never gives you an answer. He just says, 'I'm a no.' He thinks he's going to get publicity.' The bill Trump wants to see passed features major components of the president's agenda, including the extension of the 2017 Trump tax cuts, $50 billion to renew construction of Trump's border wall and a committed $150 billion in defense spending to be used for shipbuilding and a missile defense system Trump calls 'The Golden Dome,' according to ABC News. The bill also tightens eligibility requirements for the Supplemental Nutrition Assistance Program (SNAP) with adults aged 55-64 and children facing additional work requirements to qualify for benefits, ABC News reports. In a Monday post on X, Massie claimed that Trump's 'big beautiful bill' would add $20 trillion of federal debt over 10 years. 'But there's another huge problem: it will increase the price of the $36 trillion of debt we already have, as bond buyers realize we aren't fiscally responsible.' Despite Trump's meeting with Republicans, in which he urged them to stick together and pass the bill, Massie is still a no, according to Politico. Republicans have a majority of 220 seats in the House of Representatives, with 213 Democrats. They can only afford three Republican 'no' votes, assuming all Democrats also vote against the bill. White House Press Secretary Karoline Leavitt said this week it was 'absolutely essential' for the Republicans to unite and pass the bill, saying, 'there is no time to waste.' Mass. Senate eyes dramatic liquor license overhaul, but long road remains Defense Department accepts Boeing 747 from Qatar for Trump's use 'Now is the time': Harvard calls for donations amid wave of federal cuts Trump set to meet with 'out of control' South African leader at the White House '90s rock legend trashes Trump after president attacks Bruce Springsteen Read the original article on MassLive.

FDA commissioner pledges to investigate mifepristone
FDA commissioner pledges to investigate mifepristone

Yahoo

time30 minutes ago

  • Yahoo

FDA commissioner pledges to investigate mifepristone

Food and Drug Administration Commissioner Marty Makary committed to reviewing the abortion drug mifepristone in a letter sent to Senator Josh Hawley (R-Mo.). 'As with all drugs, FDA continues to closely monitor the postmarketing safety data on mifepristone for the medical termination of early pregnancy,' Makary wrote to Hawley. 'As the Commissioner of Food and Drugs, I am committed to conducting a review of mifepristone and working with the professional career scientists at the Agency who review this data,' he added in the letter. Makary did not provide any further details about the forthcoming review since the abortion drug is a part of ongoing litigation. Hawley has previously pressured the agency to review the drug. Last month, the senator sent a letter to Makary urging him to review new data released on mifepristone and to 'restore critical safeguards' on the drug's use. In the same letter, he also criticized Makary for stating that he has 'no plans to take action' on mifepristone during a journalism convention. The data Hawley referred comes from a study published in April by The Ethics and Public Policy Center, a conservative think tank with a mission to 'pushback against the extreme progressive agenda.' The group claims that nearly 11 percent of women who undergo an abortion using mifepristone experience a 'serious adverse event,' which is a far higher rate than the 0.5 percent rate determined in other clinical studies. But the study is deeply flawed and filled with what researchers have called 'junk science.' The study does not clearly state the database where it obtained the nearly 865,000 insurance claims on prescribed mifepristone abortions. The research breaks down the 'serious adverse events' by category but places the majority of those events into a vague category called 'other abortion-specific complications.' The FDA first approved the use of mifepristone for an abortion as part of two-drug regimen with misoprostol in 2000. Medication abortions do not need to take place in a clinic setting with patients able to pick up the pills at a clinic to then take home or receive them in the mail. More than 100 scientific studies have been conducted examining the safety and efficacy of mifepristone and misoprostol, with all of them finding that the drugs are a safe way to end a pregnancy. Most abortions in the U.S. are medication abortions. In 2023, 63 percent of all abortions provided by clinicians in the country were medication abortions, according to data from the reproductive health and rights group the Guttmacher Institute. Three Republican-led states — Idaho, Missouri and Kansas — filed a lawsuit against the FDA challenging its previous approval of mifepristone. The Supreme Court dismissed the case last year, arguing that private parties did not have a legal basis to challenge access to the drug. But a Texas federal judge ruled in January that the three states could resume their lawsuit aimed at restricting access to mifepristone. Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. has also pushed for a review of the drug. President Trump, after winning the election last November, said it was 'unlikely' that he would revoke access to the drug. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store